You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中藥板塊集體拉昇 國辦強調實施中醫藥振興發展重大工程
格隆匯5月20日丨華東醫藥漲超5%,同仁堂漲超4%,健民集團、嘉應制藥、片仔癀、廣譽遠等跟漲。午間消息,國務院辦公廳印發《“十四五”國民健康規劃》提出,實施中醫藥振興發展重大工程。實施中醫藥健康促進行動,推進中醫治未病健康工程升級。提升地市級以上中醫醫院優勢專科和縣級中醫醫院特色專科服務能力,力爭全部縣級中醫醫院達到醫療服務能力基本標準。豐富中醫館服務內涵,促進中醫適宜技術推廣應用。探索有利於發揮中醫藥優勢的康復服務模式。建立和完善國家重大疑難疾病中西醫協作工作機制與模式。推進中醫藥博物館事業發展,實施中醫藥文化傳播行動,推動中醫藥文化進校園。發展中醫藥健康旅遊。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account